Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.71 |
| ▸ | GLP1R | P43220 | 11/20 | 0.66 |
| ▸ | PTH1R | Q03431 | 3/20 | 0.65 |
| ▸ | ECE1 | P42892 | 1/20 | 0.65 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.65 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.61 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30446094 | 0.97 | RXFP1 (0.70) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL29462132 | 0.96 | RXFP1 (0.70) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL30183270 | 0.96 | RXFP1 (0.70) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL31453813 | 0.96 | RXFP1 (0.70) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL30635326 | 0.96 | RXFP1 (0.70) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL30271992 | 0.95 | RXFP1 (0.68) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL30183209 | 0.95 | RXFP1 (0.68) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL30874394 | 0.95 | RXFP1 (0.67) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL31087271 | 0.94 | RXFP1 (0.68) | RXFP1GLP1RPTH1RECE1MUS81 | |
| SCHEMBL30271994 | 0.94 | RXFP1 (0.68) | RXFP1GLP1RPTH1RECE1MUS81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4380962-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN Laboratories Private Limited, R&D Center (IN) | 2024-06-12 | — | — | EP | claimed |
| WO-2023012829-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2023-02-09 | — | — | WO | claimed |
| EP-4380962-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN Laboratories Private Limited, R&D Center (IN) | 2024-06-12 | — | — | EP | disclosed |
| WO-2023012829-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2023-02-09 | — | — | WO | disclosed |